HCA Healthcare Inc (HCA) FinancialsHCAFinancialHCA Healthcare Inc

Evaluating the bottom line, HCA Healthcare, Inc. maintains a gross margin of 81.07%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 15.16%, while the net margin is 9.54%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively HCA converts its operational activities into shareholder value.

In the context of the broader market, HCA competes directly with industry leaders such as THC and UHS. With a market capitalization of $90.46B, it holds a leading position in the sector. When comparing efficiency, HCA's gross margin of 81.07% stands against THC's 78.70% and UHS's 100.00%. Such benchmarking helps identify whether HCA Healthcare, Inc. is trading at a premium or discount relative to its financial performance.

HCA Healthcare reported a gross margin of 81.07% in Q2 2026, indicating strong profitability. However, net income has shown fluctuations, with a reported net income of $1.699 billion for Q2 2026, down from $1.829 billion in Q1 2026, reflecting some operational challenges.